Image Credit: Medical Buyer

D Dhanuraj, the Chairman of Centre for Public Policy Research, in talking to the Medical Buyer, comments on the risk of influx of Chinese products in India, given the increased tariffs by the US government on Chinese products.

With higher tariffs reducing China’s access to the US market, there is concern that China may divert its exports to other markets, including India, which could lead to potential dumping of goods.

The US has raised tariffs from 7.5 percent to 100 percent on a range of Chinese goods, including, lithium-ion batteries and syringes, and steel.

This situation could challenge Indian industries, particularly in sectors where competition with Chinese products is already fierce.

D Dhanuraj said the US policy to increase tariffs on EVs and solar panels are not going to benefit the global south, including India.

“In India, there could be a better chance of dumping Chinese products given the slowdown and excess production capacity that China has. The incentives and boost by the government of India to propel EVs and solar energy could be a more attractive option for dumping these products to India,” he finished.

Read the full article here.


Views expressed by the author are personal and need not reflect or represent the views of the Centre for Public Policy Research.

Leave a Reply

Your email address will not be published. Required fields are marked *